In Brief: Value Health/Diagnostek
Executive Summary
Value Health/Diagnostek: Federal Trade Commission grants early termination of the Hart-Scott-Rodino waiting period May 3, enabling Value Health to proceed with its acquisition of the prescription benefit management company Diagnostek. Avon, Conn.-based Value Health projects completion of the transaction by late June or early July pending approval from the SEC and shareholders of both companies...